title: [Initial experience with aflibercept in the management of patients with wet age-related macular degeneration refractory to ranibizumab and/or bevacizumab].
authors.affiliation: Servicio de Oftalmología, Hospital General Universitario, Valencia, España. Electronic address: Cervera_enr@gva.es.
authors.forename: R E
authors.initials: RE
authors.lastname: Cervera
authors.affiliation: Servicio de Oftalmología, Hospital General Universitario, Valencia, España.
authors.forename: V
authors.initials: V
authors.lastname: Castro
authors.affiliation: Servicio de Oftalmología, Hospital General Universitario, Valencia, España.
authors.forename: J
authors.initials: J
authors.lastname: Montero
authors.affiliation: Servicio de Oftalmología, Hospital General Universitario, Valencia, España.
authors.forename: C
authors.initials: C
authors.lastname: Torralba
authors.affiliation: Servicio de Oftalmología, Hospital General Universitario, Valencia, España.
authors.forename: A
authors.initials: A
authors.lastname: Gracia
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D000068258:Bevacizumab; D004341:Drug Evaluation; D004351:Drug Resistance; D005260:Female; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D000069579:Ranibizumab; D040262:Receptors, Vascular Endothelial Growth Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage / Q000627:therapeutic use*; D012189:Retrospective Studies; D016896:Treatment Outcome; D014792:Visual Acuity; D057135:Wet Macular Degeneration / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D011993:Recombinant Fusion Proteins; C533178:aflibercept; D000068258:Bevacizumab; D040262:Receptors, Vascular Endothelial Growth Factor; D000069579:Ranibizumab